Comparison of two modalities of aerobic training on health-parameters in adolescent obese

ISRCTN ISRCTN67155720
DOI https://doi.org/10.1186/ISRCTN67155720
Secondary identifying numbers N/A
Submission date
12/02/2016
Registration date
16/02/2016
Last edited
15/02/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Obese (very overweight) children are at a higher risk than thought of developing vascular disease (for example, atherosclerosis where the blood vessels become clogged up with fatty deposits). Vascular disease often leads to coronary heart disease, heart disease and stroke in later life. In the early stages of vascular disease, microvascular function (function of the small blood vessels) may be affected, leading, for example, to the walls of the blood vessels to stiffen or become thicker. Studies have not yet been able to show if microvascular function is affected in obese children. Despite the well-established health-related benefits of aerobic training in obese people, it is not clear yet what type and intensity of exercise works best for obese children. There is growing evidence to suggest that high-intensity interval training (HIIT) can be an effective alternative to the more traditional moderate continuous training (MCT). At present there is no information on whether HIIT might have a greater beneficial effect than MCT on the vascular function in obese people. The aims of the present study were to compare the microvascular function of obese and normal-weight adolescents and to determine the effects of three months of HIIT and MCT on microvascular function, body composition (percentage of fat, bone, muscle and water in the body), and aerobic fitness in obese adolescents.

Who can participate?
Obese adolescents aged 12-16 years and healthy normal weight adolescents aged 12-16 years.

What does the study involve?
First of all, all participants undergo a blood flow test. All obese adolescents have further tests including height, weight, body composition, fitness, microvascular function and metabolic profile (for example blood sugar levels and liver and kidney function via blood tests). The obese participants are then randomly allocated to one of two groups. Those in group 1 undergo a 3 month weight loss programme including diet and HIIT. Those in group 2 undergo a similar programme but with MCT. All obese participants undergo the same tests that they had at the start of the study after 3 months to assess its effects.

What are the possible benefits and risks of participating?
One potential benefit for obese adolescents taking part is that they have access to a supervised and well-controlled exercise training sessions that may help them to improve their level of fitness. A potential risk could be that severely obese adolescents may not be able to exercise.. All adolescents will have a complete medical check-up before starting the programme. Participants may be reluctant to have their blood taken for analysis but they can choose not to have one if they wish.

Where is the study run from?
Saint-Pierre University Hospital, Pediatric Institute (France)

When is the study starting and how long is it expected to run for?
January 2013 to June 2014

Who is funding the study?
Saint-Pierre University Hospital, Pediatric Institute (France)

Who is the main contact?
Professor Agnes Vinet

Contact information

Prof Agnes Vinet
Scientific

LaPEC, Faculty of Science 301 Rue Baruch de Spinoza - BP21239
Avignon cedex 9
84916
France

Study information

Study designInterventional non-randomised
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleMicrovascular adaptations after moderate continuous and high-intensity interval-training in adolescents with severe obesity
Study objectivesWe hypothesized that high-intensity interval-training induced better improvements in microcirculation function moderate continuous, i.e higher changes in peak cutaneous blood flow.

The aims of the study are:
1. To compare the microvascular phenotype of obese adolescents and normal-weight adolescents
2. To determine the effects of three months of high-intensity interval-training and moderate continuous training on microvascular function, body composition, metabolic markers and aerobic fitness in obese adolescents
Ethics approval(s)Local Ethics Committee (SSR Institut-Saint-Pierre, Palavas-Les-Flots, France), 06/01/2013
Health condition(s) or problem(s) studiedObesity
InterventionAt the start of the study, the cutaneous microvascular function of all participants are assessed. Obese adolescents also undergo body composition, metabolic profile and aerobic fitness assessments. They then undergo a 3-months weight loss program consisting of diet and exercise training managed by a single-pediatric weight center. They are randomly allocated into one of 2 groups of exercise training: either high-intensity interval training (HIIT) or moderate continuous training (MCT) . They all receive an identical moderately hypocaloric diet with a daily energy deficit of 500 kcal. Only the exercise training program differ in both groups. Exercise training program consists of 3 supervised sessions per week during 3 months. MCT consists of 40 to 60 min at 60-70% of maximal heart rate and HIIT program consists of (4 to 6) x (2 min to 2 min 30s) periods at 90-95% of HRmax interspersed by 1 min 30s period at 55% of HRmax. They undergo the same assessments at the start of the study at the end of the three month intervention period.
Intervention typeOther
Primary outcome measureCutaneous blood flux (CBF) was determined by means of laser Doppler flowmetry (Periflux PF 5000, Perimed, Stockholm, Sweden) equipped with a thermostatic LDF probe (PF 481, Perimed, Stockholm, Sweden), on the volar surface of the right forearm. Assessed at baseline in obese adolescents and controls, and after 3 months of intervention only in obese adolescents.
Secondary outcome measures1. Body composition, assessed only in obese adolescents at inclusion and after 3 months of intervention
2. Aerobic fitness (including the 20-meter shuttle run test), assessed only in obese adolescents at inclusion and after 3 months of intervention
3. Weight and height measurements were performed and body mass index (BMI) was calculated as weight in kilograms divided by height in squared meters (kg.m-2), at baseline and after 3 months of intervention
4. Body fat mass, abdominal and gluteal fat masses and lean body mass, assessed in only obese adolescents using dual-energy X-ray absorptiometry (DEXA), (QDR 2000 – Discovery, Hologic, Bedford, MA), at baseline and after 3 months of intervention
4. Plasma glucose, plasma insulin and lipid profile were assessed only in obese adolescents using fasting blood samples, at baseline and after 3 months of intervention
Overall study start date04/01/2013
Completion date30/06/2014

Eligibility

Participant type(s)Mixed
Age groupChild
Lower age limit12 Years
Upper age limit16 Years
SexBoth
Target number of participantsMinimum 12 subjects in each group (control and obese sub-groups of training)
Key inclusion criteria1. Obese adolescents, male or female, aged 12-16 years, non-smokers, not taking any medications and without known cardiovascular or metabolic disease
2. Healthy normal-weight pubertal stage-matched adolescents
Key exclusion criteria1. Smokers
2. Adolescents who participated in extra-school sport activities more than 2h per week
Date of first enrolment30/01/2013
Date of final enrolment10/06/2014

Locations

Countries of recruitment

  • France

Study participating centre

Saint-Pierre University Hospital, Pediatric Institute (SSR pediatrique Institut-Saint-Pierre)
71 Av de l'Eveche de Maguelone
Palavas-les-Flots
34250
France

Sponsor information

Saint-Pierre University Hospital, Pediatric Institute (SSR Institut St Pierre)
Hospital/treatment centre

371 Av de l'Eveche de Maguelone
Palavas-Les-Flots
34250
France

Website http://www.institut-st-pierre.com/
ROR logo "ROR" https://ror.org/01q046q46

Funders

Funder type

Hospital/treatment centre

Saint-Pierre University Hospital, Pediatric Institute (SSR Institut St Pierre)

No information available

Results and Publications

Intention to publish date15/08/2016
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination plan
IPD sharing plan